Skip to main content
Synbiotic SE logo

Synbiotic SE — Investor Relations & Filings

Ticker · SBX ISIN · DE000A3E5A59 LEI · 48510041U2G1IWA3R418 F Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2023-03-05 Director's Dealing
Country DE Germany
Listing F SBX

About Synbiotic SE

https://www.synbiotic.com/

Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.

Recent filings

Filing Released Lang Actions
SynBiotic SE: MARKTFLAGGE GmbH, Verleih von 20.000 Aktien im Rahmen einer Wertpapierleihe
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and by persons closely associated with them). It details a transaction (lending of 20,000 shares) involving an individual ('Sebastian Stietzel') who holds the position of 'Aufsichtsrat' (Supervisory Board member) in SynBiotic SE. This directly corresponds to the definition of Director's Dealing.
2023-03-05 German
SynBiotic SE: doinglean Ventures GmbH, Verleih von 100.000 Aktien im Rahmen einer Wertpapierleihe
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and contains a section explicitly labeled 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and by persons closely associated with them). It details a transaction (lending of 100,000 shares) involving an entity closely related to a board member ('Lars Müller', 'Vorstand'). This directly corresponds to the definition of Director's Dealing.
2023-03-05 German
SynBiotic SE: Beabsichtigte Kapitalerhohung gegen Bareinlagen mit Bezugsrecht.
Share Issue/Capital Change Classification · 98% confidence The document is an 'Ad-hoc' announcement dated February 28, 2023, explicitly titled 'SynBiotic SE: Beabsichtigte Kapitalerhöhung gegen Bareinlagen mit Bezugsrecht' (Intended capital increase against cash contributions with subscription rights). It is classified as an 'Insiderinformation gem. Artikel 17 MAR (Ad hoc-Mitteilung)'. The core subject is the planned execution of a capital increase ('Kapitalerhöhung') intended for financing further growth. This directly relates to changes in the company's capital structure and fundraising activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-02-28 German
SynBiotic SE attracts Canopy Growth founder
Board/Management Information Classification · 100% confidence The document is an official announcement released via RNS (Regulatory News Service) and EQS News. The content explicitly details the appointment of a new Chairman to a newly created Advisory Board (Bruce Linton) and mentions his investment in the company. This constitutes an announcement regarding changes in senior management/board structure. This aligns directly with the definition for Board/Management Information (MANG). Although it is distributed via a regulatory service (RNS), the core subject matter is personnel change, making MANG the most specific classification. The document is not a full report, a financial release, or a proxy statement.
2022-11-24 English
SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board
Board/Management Information Classification · 100% confidence The document is a news release dated November 24, 2022, announcing that SynBiotic SE has appointed Bruce Linton as the Chairman of its newly created Advisory Board. The content focuses entirely on personnel changes (appointment of a new chairman) and related strategic implications. This directly matches the definition for Board/Management Information (MANG). It is not an Annual Report (10-K), Earnings Release (ER), or a comprehensive Interim Report (IR). It is a specific announcement about management structure.
2022-11-24 English
SynBiotic SE: t-grove UG (haftungsbeschrankt), Acceptance of a call option on 43,720 shares at a price of EUR 15.00
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (acceptance of a call option) involving an individual associated with the company's management body (Herr Thomas Hanke) and the number of shares involved. This directly corresponds to the definition of Director's Dealing.
2022-11-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.